Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Fuhe Huaxing Pharmaceutical Group is a comprehensive pharmaceutical enterprise based in Heilongjiang Province, China. The company specializes in the research, development, and large-scale production of a wide array of pharmaceutical products, including chemical drugs and traditional Chinese medicines. Its extensive portfolio covers critical therapeutic areas such as cardiovascular health, respiratory ailments, infectious diseases, and metabolic disorders. Fuhe Huaxing operates modern, GMP-certified manufacturing facilities capable of producing various dosage forms, including tablets, capsules, and injections. The group is recognized as a key high-tech enterprise in the region and maintains a strong presence in the Chinese domestic market through its established brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Fuhe Huaxing Pharmaceutical Group.